Summary & Overview

HCPCS S0139: Minoxidil, 10 mg

HCPCS Level II code S0139 denotes Minoxidil, 10 mg, a prescription medication used in specific clinical situations. Nationally, accurate coding for medication dispensing influences pharmacy reimbursement, coverage determinations, and utilization tracking. This code matters for payers and providers managing drug billing in outpatient and ambulatory settings.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical context, typical site of service, and how it is used in claims for oral minoxidil therapy. The publication summarizes common modifiers observed with medication service lines, notes where input data is unavailable, and identifies the kinds of benchmarks and policy updates that are typically relevant for a medication billing code: coverage policies, prior authorization trends, and pharmacy billing practices.

The piece provides practical context for billing staff, pharmacists, and revenue cycle managers on how S0139 is applied in outpatient pharmacy and ambulatory clinic settings, and highlights where stakeholders should look for payer-specific policy details and coding guidance.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareS0139HCPCS Level IIminoxidiloral-medicationpharmacy-billingoutpatientdrug-codingmedication-reimbursement

Billing Code Overview

HCPCS Level II code S0139 represents Minoxidil, 10 mg. This billing code corresponds to the medication minoxidil provided in a 10 mg dosage form. The service type is medication dispensing/administration for pharmacologic therapy targeting conditions treated with oral minoxidil. The typical site of service is outpatient pharmacy or ambulatory clinic where oral medications are dispensed or administered.

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A typical scenario involves an outpatient dermatology or primary care visit where a clinician prescribes systemic oral minoxidil S0139 (minoxidil, 10 mg) for refractory androgenetic alopecia or other forms of hair loss when topical therapies or first-line agents were insufficient. The patient is evaluated for medical history, baseline vital signs (including blood pressure and heart rate), and cardiac risk factors. Documentation includes indication, prior therapies tried, informed consent discussion of off-label systemic use and potential adverse effects (edema, tachycardia, hypertrichosis), and a plan for baseline and follow-up monitoring (blood pressure checks, electrolyte review, and periodic cardiac evaluation). The medication may be dispensed from a specialty pharmacy or outpatient clinic; billing uses HCPCS Level II code S0139 for the minoxidil 10 mg product. Typical site of service is an outpatient clinic, dermatology practice, or specialty pharmacy dispensing for home administration.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier (default)	Use when no special circumstances apply to the billed service.
`22`	Increased procedural services	Use when documentation supports substantially greater work or complexity related to the service.
`23`	Unusual anesthesia	Use when medically necessary anesthesia was provided for an associated procedure.
`52`	Reduced services	Use when the service/procedure was partially reduced or not fully performed.
`53`	Discontinued procedure	Use when the procedure was started but discontinued for patient safety.
`54`	Surgical care only	Use when billing separates intraoperative surgical care from other global services.
`55`	Postoperative management only	Use when billing only postoperative care separate from the surgical service.
`56`	Preoperative management only	Use when billing only preoperative evaluation separate from the surgical service.
`62`	Two surgeons	Use when two surgeons work together as primary surgeons on a procedure.
`78`	Return to OR for related procedure during global period	Use when patient returns to the operating room for a related procedure during the global period.
`AS`	Medically necessary service performed at an Ambulatory Surgical Center	Use when the service is performed in an ASC and requires this designator for payor processing.
`QX`	Modifier for assistant at surgery (surgical assistant not certified)	Use when an assistant-at-surgery is reported and the assistant lacks required credentialing for payor recognition.
`QY`	Surgical assistant certified by the accredited standards	Use when an accredited surgical assistant participates and credentialing should be reported.
`SH`	Outpatient surgical procedures performed by a surgical assistant	Use when an assistant is involved in an outpatient surgical procedure requiring this modifier.

Taxonomy Code	Specialty	Notes
`207N00000X`	Dermatology	Most common specialty prescribing systemic minoxidil for hair disorders.
`208D00000X`	Family Medicine	Primary care clinicians may initiate therapy and monitor for adverse effects.
`208000000X`	Internal Medicine	Internists manage systemic therapy and medical comorbidities and monitoring.
`2083P0800X`	Cardiology	Cardiology consultation for patients with cardiac risk or arrhythmia concerns before systemic minoxidil.
`363L00000X`	Pharmacy	Specialty or clinical pharmacists involved in dispensing, counseling, and medication management.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`L64.0`	Androgenic alopecia [male pattern]	Primary indication for systemic minoxidil when topical therapy is inadequate.
`L64.1`	Androgenic alopecia [female pattern]	Female pattern hair loss treated off-label with systemic minoxidil in refractory cases.
`L65.9`	Nonscarring hair loss, unspecified	Used when hair loss type is unspecified but systemic therapy is indicated.
`L63.9`	Alopecia areata, unspecified	Considered when systemic therapies are trialed for severe or extensive disease.
`R68.1`	Generalized hypertrichosis	Relevant as a potential adverse effect to monitor during systemic minoxidil therapy.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, low to moderate complexity	Typical visit code when prescribing `S0139` for follow-up or medication management.
`99214`	Office or other outpatient visit for the evaluation and management of an established patient, moderate to high complexity	Used when more complex decision-making or comorbidity management is required before initiating systemic minoxidil.
`36415`	Collection of venous blood by venipuncture	Used for baseline labs (electrolytes, renal function) prior to or during therapy monitoring.
`93000`	Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	Performed when cardiac evaluation is indicated before or during systemic minoxidil therapy.
`99070`	Supplies and materials (except spectacles), provided by the physician over and above those usually included with the office visit	Used when documenting and billing for non-routine supplies or patient education materials related to dispensing.